Serologic responses to Rhodococcus equi in individuals with and without human immunodeficiency virus infection.

This research investigates how the immune responses to Rhodococcus equi, a bacteria causing pneumonia, differ between individuals with and without HIV infection, determining that a higher level of R. equi antibodies is associated with better recovery prospects.

Study Participants

• The study involved various categories of participants: healthy blood donors, workers from horse-breeding farms, persons negative for HIV but at risk, HIV-infected individuals not infected by Rhodococcus equi, and HIV-infected patients with Rhodococcus equi pneumonia.

Research Method

• Blood samples were taken from participants and tested for antibodies to Rhodococcus equi using an enzyme immunoassay (EIA), a technique used to detect and quantify specific antibodies in a sample.
• This research also included immunoblot studies, a method used to detect specific proteins, to analyze the reaction of the Rhodococcus equi-infected patients’ immune systems with the bacteria’s antigens.

Findings

• Results showed similar antibody levels against Rhodococcus equi in healthy donors, horse-farm workers, HIV-at-risk individuals, and HIV-positive subjects not infected with Rhodococcus equi.
• The group that significantly differed was the one composed of HIV-positive subjects with Rhodococcus equi infection, who had significantly higher antibody levels. This suggests a stronger immune response against the R. equi infection in these patients.
• Observation of the clinical outcomes showed a correlation between low levels of specific antibodies and more severe pneumonia, and between recovery and elevated R. equi antibody levels over time.
• Immunoblot studies showed that both Rhodococcus equi-infected patients and foals recognized a protein band of approximately 60 kDa in the Rhodococcus equi precipitate-soluble antigen. This suggests common immune responses to the infection in both groups.
• The immunoblot studies also identified that the R. equi-infected patients did not react with the 15 to 17 kDa virulence-associated proteins considered as key virulence factors in horses and mice. The lack of reaction indicates a difference in human immune responses to the bacteria compared to other animals.